Lily K Stern MD Profile
Lily K Stern MD

@LilySternMD

Followers
617
Following
1K
Media
14
Statuses
146

@ucsfalumni | @CedarsSinai Advanced Heart Disease & Transplant, cardiac amyloidosis | Singer-songwriter in a former life | Tweets my own

Los Angeles, CA
Joined June 2018
Don't wanna be here? Send us removal request.
@LilySternMD
Lily K Stern MD
2 years
1/ Check out our recent publication in @JCardFail ! The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and Methodology - https://t.co/mYuUeD3Ms7
3
17
51
@Ron_Witteles
Ronald Witteles
21 days
More incredible #CRISPR data with #Nexz published today in @NEJM -- this time 2 year data from the Phase 1 #ATTR polyneuropathy study. #TTR levels down 90% by day 28... and 92% at month 24! Improved neuropathy functionally and by #Nfl levels. Exciting prospects for #MAGNITUDE.
3
16
59
@MasriAhmadMD
Ahmad Masri
18 days
1/2 We presented exploratory data from ATTRibute-CM looking at all events - CVM and recurrent CVH - which show early and sustained effect of acoramidis throughout the study. #HFSA2025 #CardioTwitter #MedIQHFSA2025
1
6
21
@BrettSperryMD
Brett Sperry, MD
19 days
Sharing our research on slowed worsening of conduction disease with acoramidis Great session with multiple leaders in the field and great discussions!
1
3
26
@ruey_hu
Ruey Hu, MD, MPH
3 months
When people talk about "telemonitoring" in heart failure, they can be talking about very different things. Great teamwork on this systematic review by @KwaahPatrick @barbiemalaga @kassemfarhatMD @AAbdullah780 @EOlumuyideMD and collaboration with @MHBeasleyMD @LilySternMD
@KwaahPatrick
Patrick Kwaah
3 months
🚀 Thrilled to share our new manuscript: “Non-Invasive Telemonitoring in Heart Failure: A Systematic Review”! 📲❤️ Read here 👉 https://t.co/F3z2cOBZeY 1/2 ✨ #HeartFailure #Telemedicine #Cardiology #Research
0
6
18
@ManlaYosef
Yosef Manla, MD, FESC
6 months
Presented this at #ISHLT2025: In our single-center study @SmidtHeart , pre- heart transplant sensitization & older donor age were associated with immediate presentation of severe PGD-LV ⚠️. Immediate presentation = worse 30-day & 1-yr survival vs delayed presentation 📉.@ISHLT
1
5
14
@LilySternMD
Lily K Stern MD
8 months
Thank you so much for tuning in!
@EugenioCingolan
Eugenio Cingolani, MD
8 months
1
0
9
@LilySternMD
Lily K Stern MD
9 months
Thank you @ACCinTouch and @AmiBhattMD for hosting a great discussion and highlighting our research! @David_Ouyang @amey_vrudhula @SmidtHeart @CedarsSinaiMed @Ron_Witteles @Paul_P_Cheng
@ACCinTouch
American College of Cardiology
9 months
ACC CardiaCast: Innovation in Action: 🆕 Podcast Series ACC Chief Innovation Officer @AmiBhattMD is joined by Drs. @amey_vrudhula & @LilySternMD to delve into AI model training & how to leverage AI for early 🔎 of cardiac amyloidosis. 🎧 https://t.co/gWmPaExZMB #ACCInnovation
0
5
17
@ManlaYosef
Yosef Manla, MD, FESC
10 months
I am excited to share our recent publication @TheJHLT, demonstrating how therapeutic plasma exchange improves survival in patients experiencing severe primary graft dysfunction after heart transplantation. Link: https://t.co/tWKpDOWG0l Beyond grateful to my mentor,
1
9
31
@SmidtHeart
Smidt Heart Institute at Cedars-Sinai
9 months
Don’t forget to register for the upcoming HFpEF Summit. Hear from internationally recognized leaders in the areas of clinical, translational & biological studies of heart failure with preserved ejection fraction #HFpEF 👉 https://t.co/moH7sCHwNS Beverly Hills, CA March 19-21
Tweet card summary image
hfpefsummit.org
Join the HFpEF Summit, March 19–21, 2025, at The Maybourne Beverly Hills. Connect with global leaders in HFpEF research.
0
7
17
@Ron_Witteles
Ronald Witteles
1 year
🚨🚨🚨 MAJOR news in the #amyloidosis world this morning with positive topline results of #HELIOS-B. #Vutrisiran met all primary & secondary endpoints. Let's break down what we know... #StanfordAmyloidCenter (1/13)
3
60
170
@DrMarthaGulati
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦
1 year
When the #womenincardiology get together in #SoCal, it is the best! @CaliforniaACC @JanetWeiMD @netta_doc (missing because of 🦷) Male Allies always welcome like the amazing @datsunian (with future #WIC) @LilySternMD @USC_Cardiology @SmidtHeart
2
9
81
@David_Ouyang
David Ouyang, MD
1 year
Second first author research publication by star @SarnoffCardio fellow and soon to be @StanfordMedRes @amey_vrudhula! @LilySternMD @Paul_P_Cheng @pieroricchiuto @Ron_Witteles @JigPatelMDPhD
1
10
54
@David_Ouyang
David Ouyang, MD
2 years
Working with expert clinicians like @LilySternMD and @JigPatelMDPhD here at @SmidtHeart and similar amyloid specialists at the four sites, we are focused on bringing the right diagnoses to the right patients, and use AI facilitate timely and effective care.
1
2
7
@LilySternMD
Lily K Stern MD
2 years
2/ CARS (Cardiac Amyloidosis Registry Study) The largest multicenter registry of diverse CA pts (both AL & ATTR) in the US Investigates real-world data not available in clinical trials: ✅ Natural history ✅ Treatment patterns ✅ Outcomes ➡️ Plan for international collaboration
1
1
5
@MaryjaneFarrMD
Maryjane Farr MD MSc, FACC FAST FHFSA FAHA
2 years
The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and Methodology - Journal of Cardiac Failure https://t.co/xKlhhikoJm @JLGrodin @utswheart @UTSWNews Great work Justin
1
11
39
@robmentz
Robert Mentz, MD
2 years
Hey ya'll, sharing my excitement this AM to see the incredible articles @JCardFail New articles from Cardiac Amyloidosis Registry Study (CARS), International Consortium on PGD, etc Plus AMAZING illustrations! JCF=your home for HF! Thx 4 sending ur science https://t.co/Cp01dowZha
0
17
71